secwatch.observer — SEC 8-K summary
======================================

Issuer:     GE HealthCare Technologies Inc. (GEHC)
CIK:        0001932393
Form:       8-K
Filed at:   2025-10-29T23:59:59+00:00
Accession:  0001932393-25-000052
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GE HealthCare Q3 revenue up 6% to $5.1B; adjusted EPS down to $1.07 from $1.14; raises low end of FY guidance
--------------------------------------------------------------------------------

- Revenue $5.1B (+6% reported, +4% organic); organic orders +6% across all segments.
- Net income $446M ($0.98 diluted EPS) vs $470M ($1.02); adjusted EPS $1.07 vs $1.14.
- Segment EBIT margin declines: Imaging 10.2% (-260bps), Patient Care Solutions 3.7% (-680bps), Pharmaceutical Diagnostics 29.4% (-150bps).
- Full-year adjusted EPS guidance low end raised to $4.51-$4.63 (prev $4.43-$4.63); organic revenue ~3% growth reaffirmed.
- Management cites ~$265M tariff impact on adjusted EBIT and $0.45 on adjusted EPS; free cash flow $483M vs $651M prior year.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1932393/000193239325000052/0001932393-25-000052-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1932393/000193239325000052/gehc-20251029.htm
  HTML page:      https://secwatch.observer/filing/0001932393-25-000052

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer